CD4 and cancer: The fact that p53-specific CD4+ T cells were frequently observed in healthy donors and both seropositive and seronegative cancer patients in contrast to CD8+ T cells suggested that central and/or peripheral tolerance against CD4+ T cells is weak or absent, as indicated by studies in mice [43].